The pandemic caused our teams all over the world to go into lockdown, starting in Asia and specifically China…
At Servier, above and beyond strictly commercial objectives, our marketing activities are aimed at providing medical information of the utmost quality.
Our marketing teams are present in more than 70 countries and are recognized around the world for their high level of scientific excellence. We owe this to our demanding recruitment policy and excellent internal training.
Since 5 May 2008, Servier has been committed to a quality approach based on the continuous improvement of information practices. This is done through prospecting undertakings aimed to promote medicines in accordance with the Charter signed by the French Association of Pharmaceutical Companies (Les Entreprises du Médicament – LEEM) and The Economic Committee for Health Products (Comité Economique des Produits de Santé – CEPS).
We have established relationships of trust with all of our stakeholders, whether healthcare professionals or patients.
All our marketing tools are attuned to their expectations, from the packaging of our medicines to the sales materials provided.
Our operational activities have made us No. 2 in Europe in the field of cardiology and the second leading French company in all therapeutic areas.
Our collaboration with the medical and scientific community is geared towards one major priority: Improving the lives of patients.
Thanks to new technologies sweeping across the world of healthcare, Servier can now provide a complete system of patient care with services focused on prevention, diagnosis, and therapeutic solutions (medicinal and digital), not just the medicinal product.
Servier’s promotional tools reflect this comprehensive approach to care devoted to therapeutic progress.